ClinicalTrials.gg
TerminatedNCT07090018Updated Oct 6, 2026

Empowered Relief: A One-Time Session to Help Postpartum Women Manage Ongoing Pain After Cesarean Delivery

An interventional study of Empowered Relief in Chronic Pain and Cesarean Section Complications, sponsored by Stanford University. Terminated at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
unable to enroll participants with current study design
Updated Oct 6, 2026Now TerminatedStudy documents posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 47 studies in Chronic Pain by Stanford University — 14 open to participants now, 18 under way, 1 of them phase 3. Chronic Pain · Stanford University.

Enrollment
34th of 37
1 · median 80
Started
2025
with 2 others
No phase
25 of 47
7 open now
Registered
42nd of 47
by date

Among the 47 studies in Chronic Pain by Stanford University, this one is the 34th largest by enrollment of the 37 interventional ones that give a count, is one of 3 that started in 2025, is one of 25 with no phase, and was the 42nd registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

14 of the 47 studies in Chronic Pain by Stanford University are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 47 studies in Chronic Pain by Stanford University, or all of them as a file.
02

Study summary

The purpose of this study is to study the effect of a pain relief skills session (Empowered Relief) on chronic pain incidence at 12 weeks post cesarean delivery.

03

Conditions studied

  • Chronic Pain
  • Cesarean Section Complications

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Females 18 years of age or older
  • Any postpartum woman who has had a cesarean delivery in the Stanford Healthcare system with a viable birth
  • has moderate/severe pain, scoring ≥ 4/10 on the numerical/visual analog scale that continues at 6 weeks postpartum
  • English fluency
  • Ability to adhere to and complete study protocols
  • Access to smart device for zoom / video meetings

Exclusion criteria

Exclusion Criteria:

  • \<18yrs
  • Chronic pain prior to pregnancy
  • Cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material and/or full participation in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1 participant (actual)

Study arms

  • Experimental
    1-Session pain relief skills session (Empowered Relief)

    Participants will attend an Empowered Relief session at the beginning of the study period. Empowered Relief is a 2-hour one session pain relief skills intervention that is delivered to patients by a certified instructor using a standardized treatment manual and slide deck. Content includes completion of a pain survey, pain neuroscience education, information on pain and stress responses, experiential exercises, information on three core pain management skills, completion of a personalized plan for empowered relief, and receipt of a binaural app for daily use. Standard of care will be maintained for all participants, and supplemented with Empowered Relief. Pain management is not a factor for inclusion/exclusion criteria and patients will continue their pain management as prescribed and directed by their provider

    Behavioral: Empowered Relief

  • No intervention
    Control arm: Postpartum Standard of Care

    Participants will follow their current standard of care.

Interventions

  • BehavioralEmpowered Relief

    The participants will attend a pain relief skills intervention (Empowered Relief). The two-hour session is delivered by a certified instructor and includes pain neuroscience education, 3 core pain management skills, experiential exercises, completion of a personalized plan for empowered relief. Participants download a binaural relaxation audio file for daily use.

    Also known as: 1-Session Pain Relief Skills Intervention

06

What researchers measure

Primary outcomes

  1. Percentage of participants registering for Empowered Relief session

    Time frame: Baseline (up to 1 week)

  2. Percentage of participants attending Empowered Relief session

    Time frame: Treatment (up to 2 weeks)

  3. Participant Satisfaction Scale Score

    Participant satisfaction will be measured using a 7 item questionnaire (scale ranges from 0 - 42, higher ratings represent greater satisfaction with the treatment).

    Time frame: 1 - 2 weeks Post treatment

  4. Participant Treatment Skills Use Scale Score

    Participant treatment skills use will be measured with a 5 items questionnaire (scale ranges from 0 - 25, higher ratings represent increased time using treatment).

    Time frame: 4 - 6 weeks Post Treatment

Secondary outcomes

  1. Change from baseline in PROMIS Pain Interference 8a scale score

    Participants complete Patient Reported Outcomes Measurement Outcomes System (PROMIS) Pain Interference 8a questionnaire, an 8-item scale assessing pain interference with life enjoyment, concentration, and daily activities over the past 7 days. (Score range 8 - 40, higher scores represent a greater degree of pain interference).

    Time frame: Baseline, Week 6

  2. Change from baseline in PROMIS Pain Intensity 3a scale score

    Participants complete PROMIS Pain Intensity 3a questionnaire, a 3-item scale assessing average pain intensity for the past 7 days. (Score range 3 - 15, higher score represents a greater degree of pain intensity)

    Time frame: Baseline, Week 6

  3. Change from baseline in Pain Catastrophizing Scale Score

    Participants complete Pain Catastrophizing questionnaire, a 13-item scale assessing an individual's pain experience (Score range 0 - 52, higher score represents a greater degree of pain catastrophizing)

    Time frame: Baseline, Week 6

  4. Change from baseline in PEG scale score (composite)

    Participants complete thrice weekly Pain, Enjoyment, General Activity Scale (PEG) questionnaire, a 3-item scale assessing pain interference and intensity via SMS. (Score range 0 - 30, higher score represents a greater degree of pain intensity/interference)

    Time frame: From enrollment to the end of study completion at 6 weeks

  5. Change from baseline in PEG scale score (pain interference)

    Participants complete thrice weekly PEG questionnaire, to assess pain interference via SMS. (Score range 0 - 20, higher score represents a greater degree of interference)

    Time frame: From enrollment to the end of study completion at 6 weeks

  6. Change from baseline in PEG scale score (pain intensity)

    Participants complete thrice weekly PEG questionnaire to assess pain intensity, via SMS. (Score range 0 - 10, higher score represents a greater degree of pain intensity)

    Time frame: From enrollment to the end of study completion at 6 weeks

  7. Response rate to individual items of the PEG scale score via SMS

    Participant percentage responding to items of the thrice weekly PEG questionnaire, a 3-item scale assessing pain interference and intensity via SMS. (Score range 0 - 3; higher scores indicate higher response rate)

    Time frame: From enrollment to the end of study completion at 6 weeks

07

Study locations

1 site
  • Stanford University
    Palo Alto, California 94304, United States
08

References and documents

Publications

  • Ciechanowicz S, Joy RR, Kasmirski J, Blake L, Carvalho B, Sultan P. Incidence, Severity, and Interference of Chronic Postsurgical Pain After Cesarean Delivery: A Systematic Review and Meta-analysis. J Clin Anesth. 2025 Jun;104:111832. doi: 10.1016/j.jclinane.2025.111832. Epub 2025 Apr 24. PubMed 40279839 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Supporting information: Study protocol

Time frame: Beginning 9 months and ending 36 months following article publication.

Access criteria: Wish whom? Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For what types of analysis? For individual participant data meta-analysis By what mechanism will data be made available? Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting proposals and accessing data may be found at (Link to be provided).

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Sep 2025 to primary completion in Sep 2026, 12 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: primary completion Dec 2026 → Sep 2026 and completion Dec 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2025
First posted
Jul 29, 2025
StartActual
Sep 25, 2025
Primary completionActual
Sep 30, 2026was Dec 2026
CompletionActual
Sep 30, 2026was Dec 2026
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Terminated unable to enroll participants with current study design
changed Oct 6, 2026
Primary completion
Dec 2026→Sep 30, 2026 (actual)
Oct 6, 2026
Study completion
Dec 2026→Sep 30, 2026 (actual)
Oct 6, 2026
Enrollment
60 (estimated)→1 (actual)
Oct 6, 2026
Documents
Show all 1 update
  1. Oct 6, 2026
    Enrolling by invitation→Terminated
    Why stopped unable to enroll participants with current study design
    Primary completion Dec 2026→Sep 30, 2026 (now actual)
    Study completion Dec 2026→Sep 30, 2026 (now actual)
    Enrollment 60 (estimated)→1 (actual)
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07090018
Responsible party
Pervez Sultan (Professor of Anesthesiology, Perioperative and Pain Medicine (Obstetrics), Stanford University) — Principal investigator
First posted
Jul 29, 2025
Start date
Sep 25, 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026
Last update
Oct 6, 2026

Study contacts

Pervez Sultan, MBChB, FRCA, MD(Res)
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion